AI clinical trial finder / Skin cancer and melanoma
AI clinical trials in skin cancer and melanoma: open or opening soon
19 studies that use artificial intelligence or machine learning and are recruiting or about to recruit, from ClinicalTrials.gov (updated 2026-11-05).
Before you contact a study: a listing here is not a recommendation. Check the eligibility criteria and contacts on the official ClinicalTrials.gov page, and discuss any trial with your own doctor. Taking part is voluntary, and you can usually leave a study at any time.
Most common countries with study sites
France (3)United States (3)Sweden (3)Denmark (2)Spain (2)Australia (1)Canada (1)Turkey (Türkiye) (1)Greece (1)Switzerland (1)Puerto Rico (1)United Kingdom (1)Germany (1)Italy (1)
Studies
Full, filterable list: search ClinicalTrials.gov.
How to use this list
- Open a study to see who can take part (age, diagnosis, previous treatment) and the contact details of the study team.
- Interventional studies test a tool or treatment; observational studies collect data, for example to develop or check an AI model.
- Phase applies to medicines; many AI and device studies show "not applicable".
- Status, dates and titles are shown as the study sponsors registered them; check the study page for the latest status.
- Ask your doctor whether a study fits your situation before you apply.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Search: condition "Melanoma OR Skin Cancer" with terms for artificial intelligence, machine learning, deep learning, large language model or neural network; status recruiting or not yet recruiting. Healthcare with AI is not involved in any of these studies.